Single-port robotic nephropexy for symptomatic nephroptosis in a young female: A case report
Abstract
A 21-year-old woman with Ehlers-Danlos syndrome presented with symptomatic right renal mobility. Standing IV pyelogram demonstrated a 7 cm descent of the right kidney without hydronephrosis. She underwent a retroperitoneal single-port nephropexy without complications. At three months, imaging confirmed stable renal position with complete symptom resolution. This case highlights single-port robotic nephropexy as a safe and effective minimally invasive treatment with favorable short-term outcomes.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.